22nd International Symposium on Medicinal Chemistry

  • Author/Organiser: German Chemical Society (GDCh) Division of Medicinal Chemistry and the German Pharmaceutical Society (DPhG) Section of Pharmaceutical/Medicinal Chemistry
  • Event Website: http://www.ismc2012.org/
  • Event Date: 02 September 2012 to 06 September 2012
  • Event Type: Conference
  • Venue: Berlin, Germany
  • Associated Societies: Gesellschaft Deutscher Chemiker (GDCh), Germany

View Full Event Details

This symposium will cover drug discovery advances in all major therapeutic areas as well as the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. Particular emphasis will be put on first time disclosures. ISMC 2012 will also illustrate the impact of the -omics and biomarker areas on the interfaces between chemistry, informatics, biology and experimental medicine.


It traditionally attracts experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development.


Topics:

  • Antibody-Drug Conjugates - Finally Ready for Prime Time? (ACS Session I)
  • Antiinfectives and the Resistance Problem
  • Challenges and Opportunities for Drug Metabolism in Drug Discovery and Preclinical Drug Development (AFMC Session)
  • Chemical Biology Approaches in Drug Discovery
  • Chemistry and Stem-cell Research - Small Molecule Modulation of Stem Cells for Regenerative Medicines
  • Designing Better Drugs: Ligand Efficiency Guided Optimization in Drug Discovery (ACS Session II)
  • Drug Safety: What Toxic Effects can be Reasonably Predicted?
  • Emerging Drugs – Case Studies of Recently Disclosed New Medicines
  • Epigenetics - An Area Offering Formidable Challenges and Opportunities for Medicinal Chemists
  • Fighting Cancer : Kinases and Beyond
  • First Time Disclosures
  • Hot Trends in Process Chemistry
  • Intractable Targets: is Bigger Better?
  • Late Breaking News
  • Metabolic Disorders
  • Molecular Therapies for Inflammatory and Autoimmune Diseases
  • New Developments in CNS Drug Research
  • New Opportunities in Lead Discovery
  • New Small Molecule Approaches for Neglected Diseases
  • Next Generation of Cardiovascular Drugs
  • Predictive Tools, Virtual Screening and Cheminformatics
  • Recent Highlights in Medicinal Chemistry
  • Strategies to Tackle Challenging Targets in Oncology
  • Synthetic Chemistry: from Nano to Macro (EuCheMS Session)
  • Targeting Protein-protein Interactions
  • The impact of Transporters in Drug Discovery and Oral Bioavailability Enhancement (EUFEPS Session)
  • What's New in GPCR Research?



ChemMedChem
also published the Book of Abstracts. Natalia Ortúzar and Scott Williams from the ChemMedChem Editorial Office will be attending the symposium along with other Wiley colleagues, so please visit the Wiley booth in the exhibition area.

Article Views: 2366

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH